Search Results - "Cancer Cell International"

Search alternatives:

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor by Hao Zhang, Guoyan Liu

    Published 2025-06-01

    Abstract GSDMB, a key protein in pyroptosis, is closely linked to various diseases. Nanomaterials can target and regulate specific pathways. Herein, we report a simple and efficient one-step method to develop multi-enzyme nanoparticles capable of suppressing GSDMB expression. 0.5ZnO@Cu5.4O can inhib...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  2. 2

    The role of physical activity and epigenetic changes in colorectal cancer prevention by Yu Sun, Ooi Boon Keat, Sogand Rajabi

    Published 2025-06-01

    Abstract Regular and consistent physical activity significantly reduces the risk of colorectal cancer (CRC) by approximately 24% in men and 23% in women. There are several mechanisms through which exercise can help protect against CRC. For example, it can reduce chronic inflammation, boost the immun...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  3. 3

    Palmitoylation regulators drive the progression of clear cell renal cell carcinoma through Inhibition of cuproptosis: insights into the role of ZDHHC18 by Wei Xu, Xiao-chao Chen, Yang Wang, Jian-chun Chen, Zhi-jun Cao, Ru Huang, Chao Chen, Dao-rong Hou, Min-jun Jiang, Chen Xu

    Published 2025-06-01

    Abstract Background Protein palmitoylation is a reversible post-translational modification that increases protein hydrophobicity, which can affect protein localization, stability, and function. Although palmitoylation is frequently observed in various cancers, the specific mechanisms by which it inf...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  4. 4

    Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects by Can Lu, Muhammad Tufail, Can-Hua Jiang, Ning Li

    Published 2025-06-01

    Abstract This review examines the growing role of exosomes and circulating exosomal biomarkers in predicting response to immune checkpoint inhibitors (ICIs) in cancer therapy. While ICIs have revolutionized cancer treatment, predicting patient response remains a major challenge. Exosomes, small extr...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  5. 5

    Correlation between the use of dried Toad skin-radix clematidis and the development of intestinal dysbiosis and colorectal cancer by Xue-yan Wang, Li-jun Pan, Bing Yang, Yang Liu, Dong-xin Tang

    Published 2025-06-01

    Abstract Objective To examine the impact of different intestinal microbiota conditions on the absorption of couplet medicines (dried toad skin and radix clematidis) into the bloodstream, and to evaluate the therapeutic effects of drug-containing plasma, produced under different intestinal microbiota...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  6. 6

    Prognostic value of a lncRNA signature in early-stage invasive breast cancer patients by Rong Guo, Xiting Wang, Yinju Yang, Jiaying Zou, Ming Li, Zeying Li, Yuan Yan, Nan Lan, JianYun Nie, Yiyin Tang, Guojun Zhang

    Published 2025-06-01

    Abstract Background Existing staging approaches fall short in precisely forecasting the likelihood of recurrence and survival outcomes among patients undergoing surgery for early-stage breast cancer (EBC). Our study hypothesized that multivariate long non-coding RNA (lncRNA) expression profiles, whe...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  7. 7

    The ADAMTS2 metalloproteinase inhibits tumor growth by regulating the innate immune system by Loïc Joannes, Laura Dupont, Louis Stock, Esther Arpigny, Pascale Hubert, Marie Ancion, Margaux Luyckx, Joan Abinet, Wen Peng, Didier Calaldo, Agnes Noel, Thomas Marichal, Michael Herfs, Christophe Deroanne, Alain Colige

    Published 2025-06-01

    Abstract Background ADAMTS2 is a metalloproteinase known to be implicated in collagen maturation and regulation of (lymph)angiogenesis. As these properties are likely to alter tumor progression, we aimed to assess the overall impact of ADAMTS2 on cancer development. Methods and results Using publicl...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  8. 8

    Regulation of disease signaling by YOD1: potential implications for therapeutic strategies by Jiawei Zhao, Xiaotong Guo, Houzhong Li, Yujing Chen, Jingjing Du, Juzheng Zhang, Jinfeng Gan, Peitao Wu, Siqi Chen, Xinwen Zhang, Jinfeng Yang, Jiamin Jin

    Published 2025-06-01

    Abstract YOD1 (OTUD2) is a pivotal deubiquitinating enzyme (DUB) of the Otubain family. It plays an essential role in protein degradation and the regulation of cell signal transduction, influencing various biological processes. The activity of YOD1 is mediated through its three structural domains: t...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  9. 9

    A novel mesothelioma molecular classification based on malignant cell differentiation by Jun Liu, Yifan Liu, Yuwei Lu, Wei Zhang, Jiale Yan, Bingnan Lu, Yuntao Yao, Shuyuan Xian, Donghao Lyu, Jiaying Shi, Yuanan Li, Xinru Wu, Chenguang Bai, Jie Zhang, Yuan Zhang

    Published 2025-06-01

    Abstract Background The high heterogeneity and multi-directional poor differentiation of tumor cells in mesothelioma (MESO) contributes to tumor growth and malignant biological behaviors. However, a molecular classification based on differentiated states of tumor cells remains void. Methods We perfo...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  10. 10

    ACK1 condensates promote STAT5 signaling in lung squamous cell carcinoma by Andong Liu, Xia Lu, Yanyang Song, Jiaying Pei, Ruozheng Wei

    Published 2025-06-01

    Abstract Background ACK1, a non-receptor tyrosine kinase, phosphorylates various substrates involved in cancer progression. Its oncogenic activity is driven by gene amplification, mutations, and post-translational modifications. However, additional regulatory mechanisms that govern ACK1 activity rem...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  11. 11

    Integrated transcriptome analysis and combinatorial machine learning to construct a homeostatic model of acetylation for ccRCC and validate the key gene GCNT4 by Baohua Zhu, Ziyang Mo, Yi Bao, Xinxin Gan, Linhui Wang

    Published 2025-06-01

    Abstract Background Clear cell renal cell carcinoma (ccRCC) is one of the most common malignant tumors of the urinary system. Protein acetylation plays a key role in regulating cellular processes and cancer signaling pathways. This study explores the potential biological mechanisms of ccRCC from the...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article
  12. 12

    Cuproptosis: a novel therapeutic mechanism in lung cancer by Cheng Luo, Xinhui Wu, Shipeng Zhang, Junwen Tan, Yuzhi Huo, Xinyue Zhang, Bo Ning, Yuanhang Ye, Fei Wang

    Published 2025-06-01

    Abstract Background Lung cancer, one of the most prevalent and deadly malignant tumors, is increasingly common globally in terms of both morbidity and mortality rates. Unlike pyroptosis and necroptosis, cuproptosis is a non-apoptotic programmed cell death process. Studies have demonstrated that cupr...

    Full description

    “…Cancer Cell International…”
    Get full text
    Article